Response to letter to the editor; ANE-O-03-12-096.
E H
EH
Henriksen
U
U
Ljøstad
A
A
Tveiten
H
H
Naess
L
L
Thomassen
A
A
Mygland
D002545:Brain Ischemia / Q000188:drug therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator